Ankur Capital is an early-stage venture capital firm investing in digital and deep science technology companies building breakthroughs for a better world. We aim to uncover and unlock opportunities in overlooked markets from India to the world.

Jiny

Ankur Capital

👋 We're an early-stage venture capital firm investing in digital, deep science and climate tech companies. With a decade of experience under our belt, we uncover and unlock opportunities in overlooked markets across India. 

We're excited about going beyond digital India to digitalizing India - addressing the next 500 million with products and business models that will reshape industries.

We also believe that deep science innovation is critical to unlock a $10 Trillion economy. Case in point - digitalization has transformed healthcare through telemedicine and electronic health records but deep science is necessary for fundamental breakthroughs in understanding diseases, developing new treatments and drugs, and advancing personalized medicine.

Finally, Ankur Capital is at the helm of a new sustainability-led model of growth. We back climate tech advancing decarbonization and enabling adaptation and resilience. 

Follow us, stay tuned on our portfolio and gain valuable insights on tech and market trends shaping breakthroughs. Subscribe to our newsletter: https://lnkd.in/geaJC9ht

Climate change is front and centre in the global discourse - and with good reason - 2023 was officially the hottest year recorded.

The bright spot in a bleak situation is an accelerating global effort to tighten the belt on carbon and embrace the transformative potential of innovations to foster a greener future.

Along with policy and industry, the success of India’s net-zero story demands contextually-developed new technologies and business models that can mitigate GHG emissions and enable the economy to adapt. Ankur’s vision for 2024 reaffirms that unlocking what’s good for the planet makes for a good investment opportunity.

We remain committed in our mission to back founders building breakthroughs for a better world!

Check out Ankur Capital's 'Cli-Mates' 👉 https://lnkd.in/dJUU-utF

2023 was the year India landed on the moon, developed ever more sophisticated AI systems for diagnostics, and doubled down on innovating a path to net zero. Year-on-year the entrepreneurial bug is biting more scientists and 2023 was a testament to India's burgeoning deep science tech ecosystem.  

Wrapped 2023: TechSprouts covers the latest, most valuable insights on science-backed breakthrough innovations. In case you missed them, we bring you 12 exclusives to round-up the biggest of what's happening in frontier tech: https://lnkd.in/gGGjRhpy

Dive into what's happening in...

💡 BIOTECHNOLOGY and AI
- GenAI for accelerating novel drug discovery
- Genomics assisted breeding for developing climate friendly seed varieties
-  Enzymatic methods for long chain DNA synthesis
- Genetic testing for identifying novel disease biomarkers
-  Affordable Cell and Gene therapy in India

💡 ADVANCED MATERIALS 
- Greener alternatives in cement and steel production
- The push towards green hydrogen in India
- AI powered materials discovery to develop advanced sustainable materials
- Use of widely available materials as lithium alternatives in the battery space
- Small modular reactors for producing nuclear energy in India
 
💡ELECTRONICS & PHOTONICS 
- New age of semiconductors industry in India
- The rise of quantum technologies in India

CC: Suraj Nair and Vishal Katariya

And with that, the 2023 season comes to an end. From cutting-edge tech advancements to disruptive business models, the Indian entrepreneurial ecosystem continues to astound and inspire. This year we participated in 3 investments, and with a steadfast commitment to supporting our portfolio on the business fundamentals, we saw 78% YoY revenue growth and substantially improved profitability. We are deeply grateful for the trust our founders place in us. As we gear up for the launch of Fund III in 2024, we look forward the privilege of partnering with visionary founders dedicated to creating and transforming markets.

Finally, we couldn't have done it without the dedicated support of our team, advisors, and partners. Thank you for your contributions and insights on this mission to back founders building breakthroughs for a better world.

“Vegrow is the fastest agri-tech company to build a national presence, having done this within three years of its inception. Typically, it takes double the time to achieve this scale of operations.” - Praneeth Kumar, Co-founder, VEGROW

We are thrilled to share that VEGROW has raised  $46 million in a funding round led by GIC. 

As Vegrow's early backers, we believed in the potential of a systematic, technology led approach to unlock profits and address the myriad of challenges faced by perishable fruit supply chains. The Vegrow team's comprehensive understanding of the market and a robust tech platform has driven impact for stakeholders across the value chain. We're privileged to hav partnered with Vegrow on their journey to becoming a category leader.

Congratulations to team VEGROW! 

https://lnkd.in/diu4uZBA

Praneeth Kumar | Shobhit Jain | Mrudhukar Batchu | Kiran Naik Bhukya | Ritu Verma | Rema Subramanian | Krishnan Neelakantan

#fundraising #supplychain  #venturecapital

Local and cross-regional investors are on stage sharing perspectives on the opportunities for VC funding in the region, the investor’s role in attracting international start-ups to the region and ensuring they have the support needed to scale successfully. Moderator Mark Kahn, Managing Partner, Omnivore is joined by: 
 
Shirley Shahar, Co-Founder, DANA Venture Builder
Simon Sharp, Partner, Global Ventures 
Sherief Kesseba, Managing Partner, Climate Resilience Fund
Ritu Verma, Managing Partner, Ankur Capital
Erich Sieber, Founding General Partner, PeakBridge VC

Exploring India's unicorns and soonicorns, the eminent panel members discussed regulatory AI, digital health, bio capital, and genetic engineering. Investors emphasized the need for deep domain solutions, global IP, and early investments in innovative drugs. According to them, collaboration strategies included scaling into the US market through Chinese companies and US subsidiaries. The panel highlighted criteria like strong regulatory capabilities and a robust supply chain while addressing the government's role in funding and partnering with the private sector. #BTS2023 #BreakingBounadies #TechInnovation

🌱 Invitation: Virtual session on ESG imperative and opportunities for investors🌱

Join us for a virtual discussion on the 'ESG Imperative and Opportunities for Investors,' presented by the Indian Venture and Alternate Capital Association (IVCA) in partnership with ECube Investment Advisors, a platform committed to integrating ESG principles into business strategies.

Our panel of industry leaders – Burzin Dubash, Chief Operating Officer, Ankur Capital; Kanika Mayar, Partner, Investment and ESG Officer, Vertex Ventures, Vertex Ventures SE Asia & India; Richa Arora, Managing Partner & CEO, ESG Solutions, ECube Investment Advisors; Sanskriti Kapoor, Senior Associate - Impact and ESG, Aavishkaar Capital; and Harish H V, Managing Director, ECube Investment Advisors (moderator) – will discuss and explore the ways in which incorporating ESG practices can give rise to opportunities, alleviate risks, and contribute to the enduring sustainability of businesses.

Join us for an enriching dialogue that will deepen your understanding and help shape your strategies for a sustainable future in the alternative capital industry.

Empower your investment decisions with sustainability at its core.

For further details and inquiries, please reach out to shreya@ivca.in and jahnavi@ivca.in.

#ESGInitiatives #IVCA #MaximumIndia #ESGFactors #RiskManagement

Rajat Tandon Aakriti Bamniyal Sunitha Prasad Amit Pandey Paromita Sinha Niharika Bisht Nikita Shukla Shreya Kumar Sumeet Shetty Anirudh Garg Jahnavi Mallick Divakar K.

Betting on Bioinnovation 🧬 

Ritu Verma joins a panel discussion on *Early Stage Biopharma Investments in India* at The IITB Biopharma Summit 2023.

The Indian biopharma sector emerges as a global hub of innovation and biomanufacturing, and strategic capital infusion at the early stage is crucial to the growth of the sector.

Join us Indian Institute of Technology, Bombay on 24th November to gain valuable insights on the biopharma sector, as well as the nuances of investing in bioinnovation-led businesses.

Wadhwani Research Center for Bioengineering (WRCB) IIT Bombay | Abdur Rub | Vishesh Rajaram | Ashish Venkataramani | Ashish Ranjan, Ph.D | Nidhi Mathur

The festival of lights filled our workspace with warmth and cheer, as we came together to share wishes, laughter, creativity and colour ✨ 

Wishing you, your loved ones and your team a joyous and prosperous Diwali 🪔May the brightness of our celebrations be complemented by our commitment to a greener tomorrow!

Ankur Capital is an investment firm focused on early-stage ventures in India. The company aims to invest in and nurture innovative startups that address the fundamental needs of the Indian market, with a particular interest in technology-driven solutions across sectors such as agriculture, healthcare, and education.

COM:ANKURCAPITAL

Ankur Capital

Filings Not Available